Shanghai Zhangjiang (Group) Co., which operates the Zhangjiang Hi-Tech Park, has joined with CRO Sundia MediTech Company (桑迪亚医药技术（上海）有限公司) to expand the concept of a CRO. The two companies have formed a platform that combines Intellectual Property, CRO and Venture Capital services in one group, a biopharma incubator that includes its own CRO. The goal is take a young biopharma from original discovery into clinical trials. At the same time, the incubator will help draw the best young biopharmas to Zhangjiang Park. More details...